期刊文献+

抗菌药物体外药动/药效学模型及其在抗菌药物研发中的应用 被引量:6

In vitro pharmacokinetic models and their applications in antibiotics research
下载PDF
导出
摘要 抗菌药物体外药动/药效学模型(抗菌药物体外PK/PD模型)能够模拟抗菌药物在人体内的药代动力学过程及其杀灭细菌的动态药效学过程。用该方法研究抗菌药物与病原菌的作用比用一般稳态模型更符合体内的实际情况,同时该方法与动物感染模型相比也表现出很多优点。因此抗菌药物体外PK/PD模型在国外已经成为一种很常用的研究手段,但是在我国这种方法的采用却几乎还是空白。本文就国外抗菌药物体外PK/PD模型的基本结构、原理、发展、使用及其在抗菌药物研究开发中的应用进行综述。 The in vitro pharmacokinetic model can simulate the pharmacokinetic course of antibacterial drugs, which makes the research of drug-bacteria interaction more reliable than that with stable models. More over, the in vitro pharmacokinetic model is superior to animal infection models in many aspects. All of these make it a popular method broadly used in the antibiotics research in abroad; however, it's still a blank in our country. Here we review on the structures, principles, development and operations of the in vitro antibiotics pharmacokinetic models and its applications in the antibacterial drugs research.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2010年第5期339-345,352,共8页 Chinese Journal of Antibiotics
基金 上海市科学技术委员会科研计划项目(项目编号:09ZR1405400)
关键词 体外PK/PD模型 抗菌药物 药代动力学与药效动力学 In vitro pharmacokinetic model Antibacterial drug Pharmacokinetic and pharmacodynamics
  • 相关文献

参考文献33

  • 1史军.药物动力学和药效动力学在抗菌药物新药开发和临床治疗上的应用[J].中国临床药理学与治疗学,2007,12(2):121-133. 被引量:34
  • 2Grasso S,Meinardi G,de Carneri I,et al.New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity[J].Antimicrobial Agents and Chemotherapy,1978,13(4):570-576.
  • 3Nightingale C H,Murakawa T,Ambrose P G.Antimicrobial Pharmacodynamics in Theory and Clinical Practice[M].New York:Marcel Dekker,2002:41.
  • 4Tomita T,Ohara-Nemoto Y,Moriyama H,et al.A novel in vitro pharmacokinetic/pharmacodynamic model based on two-compartment open model used to simulate serum drug concentration-time profiles[J].Microbiol Immunol,2007,51(5):567-575.
  • 5Navashin S M,Fomina I P,Firsov A A,et al.A dynamic model for in-vitro evaluation of antimicrobial action by simulation of the pharmacokinetic profiles of antibiotics[J].J Antimicrob Chemother,1989,23(3):389-399.
  • 6Murakawa T,Sakamoto H,Hirose T,et al.New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics[J].Antimicrob Agents Chemother,1980,18(3):377-381.
  • 7Firsov A A,Chernykh V M,Navashin S M.Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model[J].Antimicrob Agents Chemother,1990,34(7):1312-1317.
  • 8L(o)wdin E,Odenholt I,Bengtsson S,et al.Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model[J].Antimicrob Agents Chemother,1996,40(11):2478-2482.
  • 9Lignell A,Johansson A,Lowdin E,et al.A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents:inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole[J].Clin Microbiol Infect,2007,13(6):613-619.
  • 10Garrison M W,Vance-Bryan K,Larson T A,et al.Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model[J].Antimicrob.Agents Chemother,1990,34(10):1925-1931.

二级参考文献31

  • 1Drusano GL,Preston SL,Hardalo C,et al.Use of preclinical data for selection of a phase Ⅱ/Ⅲ dose for evernimicin and identification of a preclinical MIC breakpoint[J].Antimicrob Agents Chemother,2001;45:13-22.
  • 2Ambrose PG,Bhavnani SM,Rubino CM,et al.Pharmacokinetics-pharmacodynamics of antimicrobial therapy:it's not just for mice anymore[J].Clin Infect Dis,2007;44:79-86.
  • 3Drusano GL.Antimicrobial pharmacodynamics:critical interactions of 'bug and drug'[J].Nat Rev Microbiol,2004;2:289-300.
  • 4Merrikin DJ,Briant J,Rolinson GN.Effect of protein binding on antibiotic activity in vivo[J].J Antimicrob Chemother,1983;11:233-238.
  • 5Mueller M,de la Pena A,Derendorf H.Issues in pharmacokinetics and pharmacodynamics of anti-infective agents:kill curves versus MIC[J].Antimicrob Agents Chemother,2004;48:369-377.
  • 6Cheung BW,Liu W,Ji P,et al.The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid[J].AAPS J,2006;8:E41-E47.
  • 7Andes D,Craig WA.Animal model pharmacokinetics and pharmacodynamics:a critical review[J].Int J Antimicrob Agents,2002;19:261-268.
  • 8Andes D,Craig WA.Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models[J].Antimicrob Agents Chemother,2002;46:1665-1670.
  • 9Andes D,Craig WA.Pharmacodynamics of a new streptogramin,XRP 2868,in murine thigh and lung infection models[J].Antimicrob Agents Chemother,2006;50:243-249.
  • 10Andes D,Craig WA.In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae:application to breakpoint determinations[J].Antimicrob Agents Chemother,1998;42:2375-2379.

共引文献33

同被引文献49

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部